Catalog

Record Details

Catalog Search


Search Results Showing Item 1 of 1


Book

Available copies

  • 7 of 7 copies available at Sage Library System.
  • 1 of 1 copy available at Hood River County Library District. (Show)

Current holds

0 current holds with 7 total copies.

Summary:

"The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar startup, by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley."
Location Call Number / Copy Notes Barcode Shelving Location Circulation Modifier Age Hold Protection Active/Create Date Status Due Date
Hood River County Library 338.7681 CAR 2018 (Text) 33892100242776 Adult Non-Fiction Book None 05/29/2018 Available -
Baker County Library 338.7681761 .C315b 2018 (Text) 37814003173516 NON-FICTION Book None 06/20/2018 Available -
Dufur School Community Library 338.76 CAR (Text) 37021000025758 NON-FICTION Book None 02/02/2021 Available -
Hermiston Public Library 338.7 CAR (Text) 37838000770982 Adult Non-Fiction Book Branch_Only_3months 11/15/2018 Available -
Milton-Freewater Public Library 338.7 Carre (Text) 37862000437186 Adult Non-Fiction Book Branch_Only_3months 03/12/2019 Available -
Pendleton Public Library 338.7 C233 (Text) 37801000608552 Adult Non-Fiction Book Branch_Only_3months 06/25/2018 Available -
The Dalles Wasco County Library 338.768 CAR (Text) 33892006412655 NON-FICTION New/High Demand None 10/05/2018 Available -

Record details

  • ISBN: 152473165X
  • ISBN: 9781524731656
  • Physical Description: x, 339 pages ; 25 cm
    print
  • Edition: First edition.
  • Publisher: New York : Alfred A. Knopf, 2018.

Content descriptions

Bibliography, etc. Note: Includes bibliographical references (page 305-324) and index.
Formatted Contents Note: A purposeful life -- The gluebot -- Apple envy -- Goodbye East Paly -- The childhood neighbor -- Sunny -- Dr. J -- The miniLab -- The wellness play -- "Who is LTC Shoemaker?" -- Lighting a Fuisz -- Ian Gibbons -- Chiat\day -- Going live -- Unicorn -- The grandson -- Fame -- The hippocratic oath -- The tip -- The ambush -- Trade secrets -- La mattanza -- Damage control -- The empress has no clothes -- Epilogue.
Summary, etc.: "The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar startup, by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley."
Subject: Theranos (Firm) History
Hematologic equipment industry United States
Fraud United States
Search Results Showing Item 1 of 1

Additional Resources